Cata-Kor Enters Research Agreement with KGK Science to Launch Human Clinical Trial on NAD+ Advanced
London, Ontario, Canada, 23 October, 2025 – Cata-Kor, a U.S.-based nutraceutical company, today announced that it has entered into a research services agreement with KGK Science Inc., a leading North American contract research organization (CRO). Under this agreement, KGK will conduct a human clinical trial evaluating NAD+ Advanced, Cata-Kor’s high-dose NAD+ formula. As part of the collaboration, […]
KGK Science Secures Class III PLA for Qlarity™, Supporting Lucid Psycheceutical’s Successful Path to Market in Canada
London, Ontario, Canada, 03 October, 2025 – KGK Science Inc., a leading North American contract research organization and regulatory consulting firm, is proud to announce the successful approval of a Class III Product License Application (PLA) for Qlarity™, a unique product developed by Lucid Psycheceuticals. This approval grants Qlarity™ its Natural Product Number (NPN), authorizing its […]
Health Canada Approves WELLEX for Human Clinical Trial, Investigating Natural Cervical Health Supplement Papillex®
London, Ontario, Canada – –WELLEX, in collaboration with Natural Products Canada, is pleased to announce that Health Canada has granted approval to proceed with a human clinical trial on its flagship product, Papillex®. This trial marks a major step forward in the company’s commitment to supporting women’s health with evidence-based natural health products. “Our goal has always […]
Unigen and KGK Science Inc. Present at Sleep 2025 and Nutrition 2025: Significant Results of Maizinol®, a Nutraceutical Ingredient, in an Objective Assessment of Sleep Parameters Measured by Actigraphy and EEG Device
A randomized, triple-blind, placebo controlled, parallel clinical trial to investigate the safety and efficacy of Maizinol® on sleep quality in a healthy population with difficulty falling asleep or staying asleep London, Ontario, Canada – Unigen Inc., a natural product R&D and proprietary ingredient supplier, featured its 2nd clinical trial results for Maizinol® sleep supplementation at SLEEP […]
KGK Science Inc. Secures Health Canada NHP License for Nutriearth’s vitamin D3 oil
London, Ontario, Canada – KGK Science Inc., a leading contract research organization specializing in clinical research and regulatory support for the nutraceutical industry, is pleased to announce the successful acquisition of a Health Canada Natural Health Product (NHP) license for Nutriearth’s groundbreaking vitamin D3 oil. This milestone ensures regulatory compliance in Canada, paving the way for […]
KGK Science and Nimble Science Partner to Revolutionize Clinical Research for GI Health
Nimble Science and KGK Science have signed a Letter of Intent to leverage their expertise and product offerings to build a stronger proposition in the market related to their respective business offerings. London, Ontario, March 11, 2025 / Globe Newswire / – KGK Science, the leading North American contract research organization (CRO) focused on designing […]
New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid
Read the article New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid using the link below: https://www.suna.org/download/members/unjarticles/2009/09apr/95.pdf
KGK Science Joins the Natural Products Association as a New Board Member
The Time is Right for Us to Be a Leader at the Table in Those Board Discussions” London, ON – As part of the growth and outreach in the natural product space on a wide range of issues, including their lead on cannabidiol, KGK Science announced today that it has joined the Board of the […]
KGK Science Applauds the Efforts of Congress to Begin Removing Regulatory Hurdles for CBD
KGK SCIENCE APPLAUDS THE EFFORTS OF CONGRESS TO BEGIN REMOVING REGULATORY HURDLES FOR CBD KGK Science, the leader in providing human clinical trials and regulatory support for the U.S. dietary supplement and nutraceutical industry and recent NPA board member, applauds the efforts of Congress to begin removing regulatory hurdles, creating a pathway to market for CBD […]
KGK Science Secures Cannabis Research License for a Clinical Trial Sponsored by New Age Nanotech
LONDON, ON (September 10, 2019) – KGK Science Inc. (“KGK”), a subsidiary of Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly”), has been issued a Cannabis Research License by the Licensing and Medical Access Directorate of Health Canada, Controlled Substances and Cannabis Branch, allowing the company to possess and administer cannabis for a Phase I human […]